The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders
Open accessAbstract
BACKGROUND: Whole-exome sequencing is a diagnostic approach for the identification of molecular defects in patients with suspected genetic disorders. METHODS: We developed technical, bioinformatic, interpretive, and validation pipelines for whole-exome sequencing in a certified clinical laboratory to identify sequence variants underlying disease phenotypes in patients. RESULTS: We present data on the first 250 probands for whom referring physicians ordered whole-exome sequencing. Patients presented with a range of phenotypes suggesting potential genetic causes. Approximately 80% were children with neurologic phenotypes. Insurance coverage was similar to that for established genetic tests. We identified 86 mutated alleles that were highly likely to be causative in 62 of the 250 patients, achieving a 25% molecular diagnostic rate (95% confidence interval, 20 to 31). Among the 62 patients, 33 had autosomal dominant disease, 16 had autosomal recessive disease, and 9 had X-linked disease. A total of 4 probands received two nonoverlapping molecular diagnoses, which potentially challenged the clinical diagnosis that had been made on the basis of history and physical examination. A total of 83% of the autosomal dominant mutant alleles and 40% of the X-linked mutant alleles occurred de novo. Recurrent clinical phenotypes occurred in patients with mutations that were highly likely to be causative in the same genes and in different genes responsible for genetically heterogeneous disorders. CONCLUSIONS: Whole-exome sequencing identified the underlying genetic defect in 25% of consecutive patients referred for evaluation of a possible genetic condition. (Funded by the National Human Genome Research Institute.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
A map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877
Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P., Church, D. M., Crolla, J. A., Eichler, E. E., Epstein, C. J., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.04.006 · Cited by 2,882
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,541
Targeted capture and massively parallel sequencing of 12 human exomes
Ng, S. B., Turner, E. H., Robertson, P. D., Flygare, S. D., Bigham, A. W., Lee, C., Shaffer, T., Wong, M., Bhattacharjee, A., Eichler, E. E., et al. (2009) · Nature · doi:10.1038/nature08250 · Cited by 2,030
Diagnostic exome sequencing in persons with severe intellectual disability
de Ligt, J., Willemsen, M. H., van Bon, B. W. M., Kleefstra, T., Yntema, H. G., Kroes, T., Vulto-van Silfhout, A. T., Koolen, D. A., de Vries, P., Gilissen, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206524 · Cited by 1,546
Structural Variation in the Human Genome and its Role in Disease
Stankiewicz, P., & Lupski, J. R. (2010) · Annual Review of Medicine · doi:10.1146/annurev-med-100708-204735 · Cited by 1,201
Self-citationRauch, A., Wieczorek, D., Graf, E., Wieland, T., Endele, S., Schwarzmayr, T., Albrecht, B., Bartholdi, D., Beygo, J., Di Donato, N., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61480-9 · Cited by 1,041
The Human Gene Mutation Database: 2008 update
Stenson, P. D., Mort, M., Ball, E. V., Howells, K., Phillips, A. D., Thomas, N. S., & Cooper, D. N. (2009) · Genome Medicine · doi:10.1186/gm13 · Cited by 873
A de novo paradigm for mental retardation.
Vissers, L. E. L. M., de Ligt, J., Gilissen, C., Janssen, I., Steehouwer, M., de Vries, P., van Lier, B., Arts, P., Wieskamp, N., del Rosario, M., et al. (2010) · Nature Genetics · doi:10.1038/ng.712 · Cited by 852
Cited by
Items 101–113 of 113
Delivery technologies for in utero gene therapy
Palanki, R., Peranteau, W. H., & Mitchell, M. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.11.002 · Cited by 64
Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery
Swingle, K. L., Billingsley, M. M., Bose, S. K., White, B., Palanki, R., Dave, A., Patel, S. K., Gong, N., Hamilton, A. G., Alameh, M.-G., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.10.031 · Cited by 64
Jagadeesh, K. A., Birgmeier, J., Guturu, H., Deisseroth, C. A., Wenger, A. M., Bernstein, J. A., & Bejerano, G. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0072-y · Cited by 56
AI-MARRVEL — A Knowledge-Driven AI System for Diagnosing Mendelian Disorders
Mao, D., Liu, C., Wang, L., AI-Ouran, R., Deisseroth, C., Pasupuleti, S., Kim, S. Y., Li, L., Rosenfeld, J. A., Meng, L., et al. (2024) · NEJM AI · doi:10.1056/aioa2300009 · Cited by 51
Self-citationUeda, K., Yaoita, M., Niihori, T., Aoki, Y., & Okamoto, N. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38337 · Cited by 46
Sadat, R., Barca, E., Masand, R., Donti, T. R., Naini, A., De Vivo, D. C., DiMauro, S., Hanchard, N. A., & Graham, B. H. (2016) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.03.004 · Cited by 38
DeepTrio: Variant Calling in Families Using Deep Learning
Brambrink, L., Kolesnikov, A., Goel, S., Nattestad, M., Yun, T., Baid, G., Yang, H., McLean, C., Shafin, K., Chang, P.-C., et al. (2021) · doi:10.1101/2021.04.05.438434 · Cited by 32
Precision Medicine for Continuing Phenotype Expansion of Human Genetic Diseases
Yu, H., & Zhang, V. W. (2015) · BioMed Research International · doi:10.1155/2015/745043 · Cited by 23
Tosco‐Herrera, E., Muñoz‐Barrera, A., Jáspez, D., Rubio‐Rodríguez, L. A., Mendoza‐Alvarez, A., Rodriguez‐Perez, H., Jou, J., Iñigo‐Campos, A., Corrales, A., Ciuffreda, L., et al. (2022) · Human Mutation · doi:10.1002/humu.24459 · Cited by 20
Bolli, N., Barcella, M., Salvi, E., D'Avila, F., Vendramin, A., De Philippis, C., Munshi, N. C., Avet‐Loiseau, H., Campbell, P. J., Mussetti, A., et al. (2017) · Cancer · doi:10.1002/cncr.30777 · Cited by 17
mvPPT: A Highly Efficient and Sensitive Pathogenicity Prediction Tool for Missense Variants
Tong, S.-Y., Fan, K., Zhou, Z.-W., Liu, L.-Y., Zhang, S.-Q., Fu, Y., Wang, G.-Z., Zhu, Y., & Yu, Y.-C. (2023) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2022.07.005 · Cited by 9
Neustadt, A., Owczarzak, J., Mu, W., Cohen, J. S., & Erby, L. (2020) · Journal of Genetic Counseling · doi:10.1002/jgc4.1223 · Cited by 7
“ES has been reported to only provide conclusive diagnoses to about 25% of patients with undiagnosed conditions, leaving the majority with unresolved diagnostic uncertainty (Berg, 2014; Sawyer et al., 2016; Yang et al., 2013).”
BackgroundInpherNet accelerates monogenic disease diagnosis using patients’ candidate genes’ neighbors
Yoo, B., Birgmeier, J., Bernstein, J. A., & Bejerano, G. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01238-2 · Cited by 4
Metadata
- Authors
- Yang, Y., Muzny, D. M., Reid, J. G., Bainbridge, M. N., Willis, A., Ward, P. A., Braxton, A., Beuten, J., Xia, F., Niu, Z., Hardison, M., Person, R., Bekheirnia, M. R., Leduc, M. S., Kirby, A., Pham, P., Scull, J., Wang, M., Ding, Y., Plon, S. E., Lupski, J. R., Beaudet, A. L., Gibbs, R. A., & Eng, C. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-10-17
- Volume
- 369
- Issue
- 16
- Pages
- 1502-1511
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2119818111
- Cited by
- 1,964
- References
- 36
- FWCI
- 127.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.